TARDBP and amyotrophic lateral sclerosis: In addition, the PARP-1 inhibitor veliparib diminished PAR levels in the nuclei of motor neurons in spinal cords of ALS patients and inhibited the formation of cytoplasmic TDP-43 aggregates in those neurons [335].